Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea

Cancer. 1972 Dec;30(6):1457-61. doi: 10.1002/1097-0142(197212)30:6<1457::aid-cncr2820300607>3.0.co;2-5.
No abstract available

MeSH terms

  • Amides / administration & dosage
  • Amides / therapeutic use
  • Amides / toxicity
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents / toxicity
  • Bone Marrow / drug effects
  • Carmustine / administration & dosage
  • Carmustine / therapeutic use*
  • Carmustine / toxicity
  • Drug Synergism
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / therapeutic use*
  • Imidazoles / toxicity
  • Lymph Node Excision
  • Melanoma / drug therapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Time Factors
  • Triazenes / administration & dosage
  • Triazenes / therapeutic use*
  • Triazenes / toxicity

Substances

  • Amides
  • Antineoplastic Agents
  • Imidazoles
  • Triazenes
  • Carmustine